Newsletter Subscription

Enter Name and Email

05 November 2011 - Brainstorming Session on BPSD at 26th ECNP Congress in Barcelona

Adrian Newman-Tancredi PhD, DSc and Prof. Przemyslaw Bienkowski MD co-led a Brainstorming Session at the 26th European College of Neuropsychopharmacology (ECNP) Congress, that took place in Barcelona (Spain) from 5th to 9th October 2013. The session debated the growing and unmet medical need for novel drug therapies to treat Behavioral and Psychological Symptoms of Dementia (BPSD). The latter is increasingly being recognized as constituting a major clinical challenge in view of the ageing population of many countries. Current pharmacotherapies employ poorly-tolerated antipsychotics that are only partially efficacious. The session examined drug discovery strategies based on in vivo profiling of novel drug candidates in a battery of behavioral models of psychosis, cognition and mood deficits.

 

Brainstorming Session Title:
Behavioral and psychological symptoms of dementia (BPSD): current drug treatment options and proposed drug discovery strategies for improved pharmacotherapeutics.

Session BS.9, Tuesday, October 08, 2013 from 07.45 - 08.45 hours.
 

Chair:   K. Oguz Karamustafalioglu, Turkey
Expert:  Adrian Newman-Tancredi, France
Expert:  Przemyslaw Bienkowski, Poland

 

For full details of the 26th ECNP Congress click here.